Immunome, Inc. - Common Stock (NQ:IMNM)
22.30
+0.39
(+1.80%)
Streaming Delayed Price
Updated: 12:14 PM EDT, May 27, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 343,038 |
| Open | 21.97 |
| Bid (Size) | 22.27 (300) |
| Ask (Size) | 22.34 (100) |
| Prev. Close | 21.91 |
| Today's Range | 21.79 - 22.61 |
| 52wk Range | 7.960 - 27.65 |
| Shares Outstanding | 87,012,328 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Immunome to Present at Upcoming Investor Conferences
February 23, 2026
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 05, 2026
The $71 Billion Cancer Shift: Why The FDA Is Speeding Up
February 05, 2026
Immunome to Present at 44th Annual J.P. Morgan Healthcare Conference
January 06, 2026
Immunome Announces Pricing of Public Offering of Common Stock
December 16, 2025
Why Immunome Stock Surged Today ↗
December 15, 2025
Frequently Asked Questions
Is Immunome, Inc. - Common Stock publicly traded?
Yes, Immunome, Inc. - Common Stock is publicly traded.
What exchange does Immunome, Inc. - Common Stock trade on?
Immunome, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Immunome, Inc. - Common Stock?
The ticker symbol for Immunome, Inc. - Common Stock is IMNM on the Nasdaq Stock Market
What is the current price of Immunome, Inc. - Common Stock?
The current price of Immunome, Inc. - Common Stock is 22.30
When was Immunome, Inc. - Common Stock last traded?
The last trade of Immunome, Inc. - Common Stock was at 05/27/26 12:14 PM ET
What is the market capitalization of Immunome, Inc. - Common Stock?
The market capitalization of Immunome, Inc. - Common Stock is 1.94B
How many shares of Immunome, Inc. - Common Stock are outstanding?
Immunome, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.